|
2024
|
G/S
|
Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific... |
|
|
Invention
|
Respiratory syncytial virus (rsv) vaccine.
The present invention relates to an mRNA sequence, co... |
|
|
Invention
|
Rsv rna molecules and compositions for vaccination.
The present invention is directed to an arti... |
|
|
Invention
|
Vaccination in elderly patients.
The present invention relates to vaccines comprising at least o... |
|
|
Invention
|
Cancer antigens. The present invention relates to tumour or cancer antigens, in particular amino ... |
|
|
Invention
|
Respiratory syncytial virus (rsv) vaccine. The present invention relates to an mRNA sequence, com... |
|
|
Invention
|
Novel lipid nanoparticle formulations for delivery of nucleic acids. The present invention provid... |
|
|
Invention
|
Vaccination with mrna-coded antigens. The present invention relates to vaccines comprising at lea... |
|
|
Invention
|
Rsv rna molecules and compositions for vaccination. The present invention is directed to an artif... |
|
|
Invention
|
Analytical method. The present invention relates to liquid chromatography methods (e.g., HPLC) th... |
|
|
Invention
|
Rna formulation. The present invention provides improved RNA-LNP formulations with lower amounts ... |
|
|
Invention
|
Cap analogs with 5'-terminal acyclic guanosine derivative. The present invention is inter alia co... |
|
|
Invention
|
Ebolavirus and marburgvirus vaccines.
The present invention relates to an mRNA sequence, compris... |
|
|
Invention
|
Artificial nucleic acid molecules.
The invention relates to an artificial nucleic acid molecule ... |
|
|
Invention
|
Flavivirus vaccine.
The present invention is directed to an artificial nucleic acid and to a pol... |
|
2023
|
Invention
|
Optimized nucleic acid molecules.
The present invention provides optimized nucleic acid molecule... |
|
|
Invention
|
Mers coronavirus vaccine.
The present invention relates to mRNAs suitable for use as mRNA-based ... |
|
|
Invention
|
Improved formulations comprising lipid-based carriers encapsulating rna. The present invention is... |
|
|
Invention
|
Nucleic acid based vaccine. The present invention is directed to nucleic acids suitable for use i... |
|
|
Invention
|
Influenza virus vaccines. inter aliainter alia directed to immunogenic compositions comprising: (... |
|
|
Invention
|
Rotavirus vaccines.
The present invention provides mRNA sequences comprising at least one coding... |
|
|
Invention
|
Nucleic acids encoding crispr-associated proteins and uses thereof.
The present invention relate... |
|
|
Invention
|
Nucleic acid encoded antibodies. The present invention relates inter alia to a nucleic acid for e... |
|
|
Invention
|
Zika virus vaccine.
The present invention is directed to an artificial nucleic acid and to polyp... |
|
|
Invention
|
Artificial nucleic acid molecules for improved protein expression.
The invention relates to an a... |
|
|
Invention
|
Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptide. Escherichia c... |
|
|
Invention
|
Rna sequence adaptation.
The present invention is directed to a method for modifying the retenti... |
|
|
Invention
|
Therapeutic nucleic acid for the treatment of ophthalmic diseases. The invention relates inter al... |
|
|
Invention
|
Method for producing rna molecule compositions.
The invention relates to a method for producing ... |
|
|
Invention
|
Rna encoding a tumor antigen.
The present invention relates to an RNA encoding a tumor antigen. ... |
|
|
Invention
|
Coronavirus vaccine. The present invention is directed to a nucleic acid suitable for use in trea... |
|
2022
|
Invention
|
Rna encoding an antibody.
The present invention relates to a RNA encoding an antibody or a fragm... |
|
|
Invention
|
Bunyavirales vaccine.
The present invention is directed to an artificial nucleic acid, particula... |
|
|
Invention
|
Linear double stranded dna coupled to a single support or a tag and methods for producing said li... |
|
|
Invention
|
Hybrid carriers for nucleic acid cargo.
A composition for the delivery of a nucleic acid compoun... |
|
|
Invention
|
Rna containing composition for treatment of tumor diseases.
The present invention relates to RNA... |
|
|
Invention
|
Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine.
The inven... |
|
|
Invention
|
Novel lipid nanoparticles for delivery of nucleic acids.
The invention relates to novel polymer ... |
|
|
Invention
|
Mrnas for treatment or prophylaxis of liver diseases.
The present invention relates to mRNA medi... |
|
|
Invention
|
Improved nucleic acid sequence for cell type specific expression.
The present invention provides... |
|
|
Invention
|
Method of reducing the immunostimulatory properties of in vitro transcribed rna.
The present inv... |
|
2021
|
Invention
|
Pharmaceutical composition comprising lipid-based carriers encapsulating rna for multidose admini... |
|
|
Invention
|
Multivalent nucleic acid based coronavirus vaccines.
The present invention is inter alia directe... |
|
|
G/S
|
Chemicals and biomolecules, in particular biological
macromolecules, for industrial or scientifi... |
|
|
Invention
|
Targets for rna therapeutics.
The present invention relates to a method for treating or preventi... |
|
|
G/S
|
Chemicals and biological preparations being biomolecules, in particular biological macromolecules... |
|
|
Invention
|
Coronavirus vaccine.
The present invention is directed to a nucleic acid suitable for use in tre... |
|
2020
|
Invention
|
Analysis of nucleic acid mixtures.
The present invention is concerned with a method for determin... |
|
2019
|
G/S
|
Chemical reagents and biomolecules, in particular biological macromolecules, for industrial or sc... |
|
|
G/S
|
Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucl... |
|
2017
|
G/S
|
Chemical reagents and biomolecules, in particular biological macromolecules for industry and scie... |
|
|
G/S
|
CHEMICAL REAGENTS AND BIOMOLECULES, IN PARTICULAR BIOLOGICAL MACROMOLECULES FOR INDUSTRY AND SCIE... |
|
2016
|
G/S
|
Chemicals and biomolecules, in particular biological macromolecules, for industrial, scientific p... |
|
2014
|
G/S
|
Chemicals used in industry and science; reagents for
research use. Chemical preparations for med... |
|
2013
|
G/S
|
Chemical products and biomolecules, namely nucleic acid macromolecules used for industrial and sc... |
|
|
G/S
|
Chemical products and biomolecules, namely, biological macromolecules used for industrial and sci... |
|
2008
|
G/S
|
Chemicals used in industry and science, namely, polynucleic acids as tools in industry and scienc... |
|
2007
|
G/S
|
Chemicals used in industry and science. Pharmaceutical and veterinary preparations. Medical and v... |
|
|
G/S
|
[ chemicals used in industry and science; reagents for research purposes ] [ Chemical reagents fo... |
|
|
G/S
|
chemicals used in industry and science; reagents for research purposes Chemical reagents for medi... |
|
|
G/S
|
Chemicals used in industry and science; reagents for research use. Chemical preparations for medi... |
|
2006
|
G/S
|
[ chemicals used in industry and science; reagents for research use ] [ Chemical preparations for... |
|
|
G/S
|
Chemicals used in industry, science and medicine; reagents for research use. Chemical preparation... |
|
|
G/S
|
Chemicals used in industry and science; reagents for research purposes Chemical preparations for ... |
|
2005
|
G/S
|
Chemicals used in industry and science; reagents for research purposes. Chemical preparations for... |
|
2002
|
G/S
|
(Priority claimed under Sec; 44D) (( Chemicals, namely, Ribonucleic-acid, deoxyribonucleic-acid, ... |
